blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2785359

EP2785359 - MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.07.2019
Database last updated on 01.04.2026
FormerThe patent has been granted
Status updated on  27.07.2018
FormerGrant of patent is intended
Status updated on  07.03.2018
FormerExamination is in progress
Status updated on  01.11.2016
Most recent event   Tooltip05.07.2019No opposition filed within time limitpublished on 07.08.2019  [2019/32]
Applicant(s)For all designated states
Astellas Institute for Regenerative Medicine
33 Locke Drive
Marlborough, MA 01752 / US
[2016/36]
Former [2014/41]For all designated states
Advanced Cell Technology, Inc.
33 Locke Drive
Marlborough, MA 01752 / US
Inventor(s)01 / LANZA, Robert
35 South Meadow Road
Clinton, Massachusetts 01510 / US
02 / KIMBREL, Erin, Anne
72 Austin Road
Sudbury, Massachusetts 01776 / US
03 / CHU, Jianlin
27 LibertyRoad
Bedford, Massachusetts 01730 / US
04 / KOURIS, Nicholas, Arthur
35 School St.
Unit A
Hudson, Massachusetts 01749 / US
 [2014/41]
Representative(s)Boult Wade Tennant LLP
Salisbury Square House
8 Salisbury Square
London EC4Y 8AP / GB
[N/P]
Former [2018/35]Boult Wade Tennant LLP
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
Former [2014/41]Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
Application number, filing date12854438.430.11.2012
[2018/35]
WO2012US67464
Priority number, dateUS201161565358P30.11.2011         Original published format: US 201161565358 P
[2014/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2013082543
Date:06.06.2013
Language:EN
[2013/23]
Type: A1 Application with search report 
No.:EP2785359
Date:08.10.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 06.06.2013 takes the place of the publication of the European patent application.
[2014/41]
Type: B1 Patent specification 
No.:EP2785359
Date:29.08.2018
Language:EN
[2018/35]
Search report(s)International search report - published on:KR06.06.2013
(Supplementary) European search report - dispatched on:EP13.10.2015
ClassificationIPC:A61K35/28, A61K35/30, A61K35/34, A61K35/36, A61K35/407, C12N5/0789, C12N5/077, C12N5/071, A61K35/39, C12N5/0775
[2018/10]
CPC:
A61K35/28 (EP,KR,US); A61F2/141 (US); A61F9/08 (US);
A61K35/30 (EP,US); A61K35/34 (EP,US); A61K35/36 (EP,US);
A61K35/39 (EP,US); A61K35/407 (EP,US); A61P1/02 (EP);
A61P1/04 (EP); A61P1/16 (EP); A61P11/00 (EP);
A61P11/02 (EP); A61P11/06 (EP); A61P13/12 (EP);
A61P17/00 (EP); A61P17/02 (EP); A61P17/06 (EP);
A61P19/00 (EP); A61P19/02 (EP); A61P19/08 (EP);
A61P21/00 (EP); A61P25/00 (EP); A61P25/16 (EP);
A61P25/28 (KR); A61P27/02 (EP); A61P27/16 (EP);
A61P29/00 (EP); A61P3/00 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P31/04 (EP); A61P31/12 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P37/00 (EP,KR);
A61P37/02 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61P7/00 (EP); A61P9/00 (EP);
A61P9/04 (EP); A61P9/10 (EP); C12N5/0647 (EP,KR,US);
C12N5/0662 (US); C12N5/0668 (EP,KR,US); C12N5/0692 (EP,KR,US);
G06F9/542 (US); A61K2300/00 (KR); C12N2501/115 (EP,KR,US);
C12N2501/125 (EP,KR,US); C12N2501/145 (EP,KR,US); C12N2501/155 (EP,KR,US);
C12N2501/165 (EP,KR,US); C12N2501/26 (EP,KR,US); C12N2502/1171 (EP,KR,US);
C12N2506/02 (EP,KR,US); C12N2506/11 (EP,KR,US); C12N2506/28 (EP,KR,US);
C12N2533/54 (EP,KR,US); G06F2218/00 (US) (-)
C-Set:
A61K35/28, A61K2300/00 (EP,US);
A61K35/30, A61K2300/00 (EP,US);
A61K35/34, A61K2300/00 (US,EP);
A61K35/36, A61K2300/00 (US,EP);
A61K35/39, A61K2300/00 (US,EP);
A61K35/407, A61K2300/00 (EP,US)
(-)
Former IPC [2015/30]A61K35/12, A61K48/00, A61K38/30, A61K38/19, A61P19/02, A61P9/00, C12N5/0775
Former IPC [2014/41]A61K35/12, A61K48/00, A61K38/30, A61K38/19, A61P19/02, A61P9/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/41]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:MESENCHYMALE STROMAZELLEN UND IHRE VERWENDUNGEN[2014/41]
English:MESENCHYMAL STROMAL CELLS AND USES RELATED THERETO[2014/41]
French:CELLULES STROMALES MÉSENCHYMATEUSES ET UTILISATION S'Y RAPPORTANT[2014/41]
Entry into regional phase26.06.2014National basic fee paid 
26.06.2014Search fee paid 
26.06.2014Designation fee(s) paid 
26.06.2014Examination fee paid 
Examination procedure26.06.2014Examination requested  [2014/41]
06.05.2016Amendment by applicant (claims and/or description)
20.10.2016Despatch of a communication from the examining division (Time limit: M06)
10.04.2017Reply to a communication from the examining division
08.03.2018Communication of intention to grant the patent
16.07.2018Fee for grant paid
16.07.2018Fee for publishing/printing paid
16.07.2018Receipt of the translation of the claim(s)
Divisional application(s)EP18186151.9  / EP3449929
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.10.2016
Opposition(s)31.05.2019No opposition filed within time limit [2019/32]
Fees paidRenewal fee
26.11.2014Renewal fee patent year 03
30.11.2015Renewal fee patent year 04
28.11.2016Renewal fee patent year 05
27.11.2017Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipSM29.08.2018
[2019/27]
Documents cited:Search[A] WO2007120811  (ADVANCED CELL TECH INC et al.) [A] 1-14 * the whole document *
 [A] WO2009137629  (ADVANCED CELL TECH INC et al.) [A] 1-22 * the whole document *
 [A] WO2009104825  (KOREA ADVANCED INST SCI & TECH et al.) [A] 15-19,22 * the whole document *
 [I]   PASCALE V. GUILLOT ET AL: "Human First-Trimester Fetal MSC Express Pluripotency Markers and Grow Faster and Have Longer Telomeres Than Adult MSC", STEM CELLS, vol. 25, no. 3, 22 March 2007 (2007-03-22), pages 646 - 654, XP055192288, ISSN: 1066-5099, DOI: 10.1634/stemcells.2006-0208 [I] 1-14,20-22 * figures 2, 3 *

DOI:   http://dx.doi.org/10.1634/stemcells.2006-0208
 [I]   KERN SUSANNE ET AL: "Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue", STEM CELLS, ALPHAMED PRESS, DAYTON, OH, US, vol. 24, no. 5, 1 May 2006 (2006-05-01), pages 1294 - 1301, XP002432657, ISSN: 1066-5099 [I] 1-14,20-22 * table 1 *
 [XI]   BARBERI T ET AL: "Derivation of multipotent mesenchymal precursors from human embryonic stem cells", PLOS MEDICINE, PUBLIC LIBRARY OF SCIENCE, US, vol. 2, 28 June 2005 (2005-06-28), pages 554 - 560, XP002404210, ISSN: 1549-1676, DOI: 10.1371/JOURNAL.PMED.0020161 [X] 18 * figure 1 * [I] 1-14,19-22

DOI:   http://dx.doi.org/10.1371/journal.pmed.0020161
 [I]   WOLFGANG WAGNER ET AL: "Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process", PLOS ONE, PUBLIC LIBRARY OF SCIENCE, US, vol. 3, no. 5, 21 May 2008 (2008-05-21), pages E2213 - 1, XP002686801, ISSN: 1932-6203, DOI: 10.1371/JOURNAL.PONE.0002213 [I] 1-14,20-22 * figure 1 *

DOI:   http://dx.doi.org/10.1371/journal.pone.0002213
 [A]   LU S-J ET AL: "Generation of functional hemangioblasts from human embryonic stem cells", NATURE METHODS, NATURE PUBLISHING GROUP, GB, vol. 4, no. 6, 1 June 2007 (2007-06-01), pages 501 - 509, XP008133153, ISSN: 1548-7091, [retrieved on 20070507], DOI: 10.1038/NMETH1041 [A] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1038/nmeth1041
 [A]   HEMATTI PEIMAN: "Human embryonic stem cell-derived mesenchymal progenitors: an overview", METHODS IN MOLECULAR BIOLOGY, HUMANA PRESS, INC, US, vol. 690, 1 January 2011 (2011-01-01), pages 163 - 174, XP009161182, ISSN: 1940-6029 [A] 1-14 * the whole document *
 [AP]   XIN FU ET AL: "Comparison of Immunological Characteristics of Mesenchymal Stem Cells Derived from Human Embryonic Stem Cells and Bone Marrow", TISSUE ENGINEERING PART A, vol. 21, no. 3-4, 1 February 2015 (2015-02-01), pages 616 - 626, XP055191852, ISSN: 1937-3341, DOI: 10.1089/ten.tea.2013.0651 [AP] 1-14 * the whole document *

DOI:   http://dx.doi.org/10.1089/ten.tea.2013.0651
 [T]   ERIN A. KIMBREL ET AL: "Mesenchymal Stem Cell Population Derived from Human Pluripotent Stem Cells Displays Potent Immunomodulatory and Therapeutic Properties", STEM CELLS AND DEVELOPMENT, vol. 23, no. 14, 15 July 2014 (2014-07-15), pages 1611 - 1624, XP055191836, ISSN: 1547-3287, DOI: 10.1089/scd.2013.0554 [T] * the whole document *

DOI:   http://dx.doi.org/10.1089/scd.2013.0554
 [XI]   MAXIM A VODYANIK ET AL: "A mesoderm-derived precursor for mesenchymal stem and endothelial cells", CELL STEM CELL, ELSEVIER, CELL PRESS, AMSTERDAM, NL, vol. 7, no. 6, 3 December 2010 (2010-12-03), pages 718 - 729, XP028211788, ISSN: 1934-5909, [retrieved on 20101202], DOI: 10.1016/J.STEM.2010.11.011 [X] 18 * material and methods;; figure 6 *[I] 19,22

DOI:   http://dx.doi.org/10.1016/j.stem.2010.11.011
 [XI]   TAN ZHOU ET AL: "Immunomodulative effects of mesenchymal stem cells derived from human embryonic stem cells in vivo and in vitro", JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, vol. 12, no. 1, January 2011 (2011-01-01), pages 18 - 27, XP002744077, ISSN: 1673-1581 [X] 18 * figures 1-3, 5 *[I] 15-17,19,22

DOI:   http://dx.doi.org/10.1631/jzus.B1000074
 [A]   MERVIN C YODER: "A Bipotent Mesoderm Subset Identified via Colony-Forming Assay", CELL STEM CELL, vol. 7, no. 6, 3 December 2010 (2010-12-03), pages 643 - 644, XP028211779, ISSN: 1934-5909, [retrieved on 20101122], DOI: 10.1016/J.STEM.2010.11.022 [A] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.stem.2010.11.022
 [A]   LU SHI-JIANG ET AL: "Robust generation of hemangioblastic progenitors from human embryonic stem cells", REGENERATIVE MEDICINE, vol. 3, no. 5, September 2008 (2008-09-01), pages 693 - 704, XP002744078, ISSN: 1746-0751 [A] 1-22 * the whole document *

DOI:   http://dx.doi.org/10.2217/17460751.3.5.693
 [A]   KSIAZEK KRZYSZTOF: "A comprehensive review on mesenchymal stem cell growth and senescence.", REJUVENATION RESEARCH APR 2009, vol. 12, no. 2, April 2009 (2009-04-01), pages 105 - 116, XP002744079, ISSN: 1557-8577 [A] 15-18,22 * the whole document *

DOI:   http://dx.doi.org/10.1089/rej.2009.0830
International search[X] US2011129918  (HUNG SHIH-CHIEH et al.)
 [Y] US2009232777  (LUNDGREN-AKERLUND EVY et al.)
 [A] WO2011097242  (UNIV ROCHESTER et al.)
 [A] US2009010896  (CENTENO CHRISTOPHER J et al.)
 [A] US2011195054  (COHEN MICHAEL et al.)
 [A] US2011123498  (WESTENFELDER CHRISTOF et al.)
 [A] KR20070114449  (IND ACADEMIC COOP et al.)
 [XP] US2012087933  (TOM SAMSON et al.)
by applicantUS8017393
 US2002103542
 EP1454641
 US8198085
 WO2004098285
 US2012077181
   THU ET AL., NAT MED., vol. 18, no. 3, 26 February 2012 (2012-02-26), pages 463 - 7
   GO ET AL., BIOCHEM., vol. 142, 2007, pages 741 - 748
   SHI ET AL., HAEMATOLOGICA, vol. 92, no. 7, July 2007 (2007-07-01), pages 897 - 904
   SASPORTAS ET AL., PROC NATL ACAD SCI USA., vol. 106, no. 12, 24 March 2009 (2009-03-24), pages 4822 - 7
   GO ET AL., J. BIOCHEM., vol. 142, 2007, pages 741 - 748
   SUH; BLELLOCH, DEVELOPMENT, vol. 138, 2011, pages 1653 - 1661
   MIYOSH ET AL., CELL STEM CELL, 2011
   SANCHO-MARTINEZ ET AL., JOURNAL OF MOLECULAR CELL BIOLOGY, 2011, pages 1 - 3
   ANOKYE-DANSO ET AL., CELL STEM CELL, vol. 8, 8 April 2011 (2011-04-08), pages 376 - 388
   ORKIN; HOCHEDLINGER, CELL, vol. 145, 10 June 2011 (2011-06-10), pages 835 - 850
   YU ET AL., SCIENCE, vol. 324, no. 5928, 8 May 2009 (2009-05-08), pages 797 - 801
   CHOI ET AL., DEVELOPMENT, vol. 125, no. 4, 1998, pages 725 - 732
   MIKKOLA ET AL., J. HEMATOTHER. STEM CELL RES, vol. 11, no. 1, 2002, pages 9 - 17
   KENNEDY ET AL., NATURE, 1997, pages 488 - 493
   PERLINGEIRO ET AL., STEM CELLS, 2003, pages 272 - 280
   YU ET AL., BLOOD, vol. 116, 2010, pages 4786 - 4794
   BORDONI ET AL., HEPATOLOGY, vol. 45, no. 5, pages 1218 - 1228
   CIRACI ET AL., BLOOD, vol. 118, pages 2105 - 2115
   SUN ET AL., BLOOD, vol. 116, no. 16, 2010, pages 2932 - 2941
   ITSKOVITZ-ELDOR ET AL., MOL MED., vol. 6, no. 2, February 2000 (2000-02-01), pages 88 - 95
   ZHOU ET AL., CELL STEM CELL, 2009, pages 1 - 4
   MIYOSHI ET AL., CELL STEM CELL, 2011, pages 1 - 6
   DANSO ET AL., CELL STEM CELL, 2011, pages 376 - 388
   KARLSSON ET AL., STEM CELL RESEARCH, vol. 3, 2009, pages 39 - 50
   GONG ET AL., J. CELL. PHYSIOL., vol. 224, 2010, pages 664 - 671
   DOMINICI ET AL., CYTOTHERAPY, vol. 8, no. 4, 2006, pages 315 - 317
   WAGNER W ET AL.: "Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process", PLOS ONE, vol. 3, no. 5, 2008, pages E2213, XP002686801, DOI: doi:10.1371/journal.pone.0002213

DOI:   http://dx.doi.org/10.1371/journal.pone.0002213
   MUSINA, R ET AL.: "Comparison of Mesenchymal Stem Cells Obtained from Different Human Tissues", CELL TECHNOLOGIES IN BIOLOGY AND MEDICINE, vol. 1, no. 2, April 2005 (2005-04-01), pages 504 - 509
   MEISEL R: "Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation", BLOOD, vol. 103, no. 12, 15 June 2004 (2004-06-15), pages 4619 - 21, XP002437352, DOI: doi:10.1182/blood-2003-11-3909

DOI:   http://dx.doi.org/10.1182/blood-2003-11-3909
   BRAUN, D: "A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation", BLOOD, vol. 106, no. 7, 1 October 2005 (2005-10-01), pages 2375 - 81, XP002367564, DOI: doi:10.1182/blood-2005-03-0979

DOI:   http://dx.doi.org/10.1182/blood-2005-03-0979
   PAREKKADAN ET AL., MOLECULAR THERAPY, vol. 20, no. 1, 2011, pages 178 - 186
   MOHANTY ET AL., STEM CELLS, vol. 30, 2012, pages 1134 - 1143
   ZAPPIA, E. ET AL.: "Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy", BLOOD, vol. 106, no. 5, 2005, pages 1755 - 61, XP002587343
   GERDONI, E. ET AL.: "Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis", ANN NEUROL, vol. 61, no. 3, 2007, pages 219 - 27, XP002603337
   LANZA, C. ET AL.: "Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in viva", J NEUROCHEM, vol. 110, no. 5, 2009, pages 1674 - 84
   RAFEI, M. ET AL.: "Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis", MOL THER, vol. 17, no. 10, 2009, pages 1799 - 803
   RAFEI, M. ET AL.: "Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th 17 T cells in a CC chemokine ligand 2-dependent manner", J IMMUNOL, vol. 182, no. 10, 2009, pages 5994 - 6002
   CONSTANTIN, G. ET AL.: "Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis", STEM CELLS, vol. 27, no. 10, 2009, pages 2624 - 35, XP055034543, DOI: doi:10.1002/stem.194

DOI:   http://dx.doi.org/10.1002/stem.194
   UCCELLI, A; D.J. PROCKOP: "Why should mesenchymal stem cells (MSCs) cure autoimmune diseases?", CURR OPIN IMMUNOL, vol. 22, no. 6, 2010, pages 768 - 74, XP027544864
   OHTAKI, H. ET AL.: "Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses", PROC NATL ACAD SCI USA, vol. 105, no. 38, 2008, pages 14638 - 43, XP055036993, DOI: doi:10.1073/pnas.0803670105

DOI:   http://dx.doi.org/10.1073/pnas.0803670105
   BARBERI, T. ET AL.: "Derivation of multipotent mesenchymal precursors from human embryonic stem cells", PLOS MED, vol. 2, no. 6, 2005, pages E161
   HWANG, N.S. ET AL.: "In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells", PROC NATL ACAD SCI USA, vol. 105, no. 52, 2008, pages 20641 - 6, XP055266736, DOI: doi:10.1073/pnas.0809680106

DOI:   http://dx.doi.org/10.1073/pnas.0809680106
   OLIVIER, E.N.; A.C. RYBICKI; E.E. BOUHASSIRA: "Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells", STEM CELLS, vol. 24, no. 8, 2006, pages 1914 - 22, XP002475361, DOI: doi:10.1634/stemcells.2005-0648

DOI:   http://dx.doi.org/10.1634/stemcells.2005-0648
   BROWN, S.E.; W. TONG; P.H. KREBSBACH: "The derivation of mesenchymal stem cells from human embryonic stem cells", CELLS TISSUES ORGANS, vol. 189, no. 1-4, 2009, pages 256 - 60, XP055100750, DOI: doi:10.1159/000151746

DOI:   http://dx.doi.org/10.1159/000151746
   KARLSSON, C.; EMANUELSSON, K.; WESSBERG, F.; KAJIC, K.; AXELL, M. Z.; ERIKSSON, P. S.; LINDAHL, A.; HYLLNER, J.; STREHL, R.: "Human embryonic stem cell-derived mesenchymal progenitors-Potential in regenerative medicine", STEM CELL RES., vol. 3, no. 1, 2009, pages 39 - 50
   LU, S. J.; FENG, Q.; CABALLERO, S.; CHEN, Y.; MOORE, M. A.; GRANT, M. B.; LANZA, R.: "Generation offunctional hemangioblasts from human embryonic stem cells", NAT. METHODS, vol. 4, 2007, pages 501 - 509
   LU, S. J.; LUO, C.; HOLTON, K.; FENG, Q.; IVANOVA, Y.; LANZA, R.: "Robust generation of hemangioblastic progenitors from human embryonic stem cells", REGEN. MED., vol. 3, 2008, pages 693 - 704, XP002744078, DOI: doi:10.2217/17460751.3.5.693

DOI:   http://dx.doi.org/10.2217/17460751.3.5.693
   KLIMANSKAYA, I.; CHUNG, Y.; BECKER, S.; LU, S.-J.; LANZA, R.: "Human embryonic stem-cell lines derived from single blastomeres", NATURE, vol. 444, 2006, pages 481 - 485, XP009076989, DOI: doi:10.1038/nature05142

DOI:   http://dx.doi.org/10.1038/nature05142
   MADSEN, L.S. ET AL.: "A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor", NAT GENET, vol. 23, no. 3, 1999, pages 343 - 7, XP002283438, DOI: doi:10.1038/15525

DOI:   http://dx.doi.org/10.1038/15525
   STROMNES, I.M.; J.M. GOVERMAN: "Passive induction of experimental allergic encephalomyelitis", NAT PROTOC, vol. 1, no. 4, 2006, pages 1952 - 60
   LIANG, J. ET AL.: "Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis", MULT SCLER, vol. 15, no. 5, 2009, pages 644 - 6
   COSTA, M. ET AL.: "The ESC line Envy expresses high levels of GFP in all differentiated progeny", NAT METHODS, vol. 2, no. 4, 2005, pages 259 - 60, XP008120057, DOI: doi:10.1038/NMETH748

DOI:   http://dx.doi.org/10.1038/NMETH748
   POMPER, M.G. ET AL.: "Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models", CELL RES, vol. 19, no. 3, 2009, pages 370 - 9
   PHINNEY, D.G; D.J. PROCKOP: "Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views", STEM CELLS, vol. 25, no. 11, 2007, pages 2896 - 902, XP002612819, DOI: doi:10.1634/stemcells.2007-0637

DOI:   http://dx.doi.org/10.1634/stemcells.2007-0637
   RYAN, J.M. ET AL.: "Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells", CLIN EXP IMMUNOL, vol. 149, no. 2, 2007, pages 353 - 63, XP008146500, DOI: doi:10.1111/j.1365-2249.2007.03422.x

DOI:   http://dx.doi.org/10.1111/j.1365-2249.2007.03422.x
   DELAROSA, 0.; E. LOMBARDO: "Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential", MEDIATORS INFLAMM, 2010, pages 865601
   ENGLISH, K. ET AL.: "IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.", IMMUNOL LETT, vol. 110, no. 2, 2007, pages 91 - 100
   BARRY, F. ET AL.: "The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells", BIOCHEM BIOPHYS RES COMMUN, vol. 289, no. 2, 2001, pages 519 - 24, XP055218830, DOI: doi:10.1006/bbrc.2001.6013

DOI:   http://dx.doi.org/10.1006/bbrc.2001.6013
   ALHADLAQ, A.; J.J. MAO: "Mesenchymal stem cells: isolation and therapeutics", STEM CELLS DEV, no. 4, 2004, pages 436 - 48, XP008118326
   MIKAMI, Y. ET AL.: "CD271/p75NTR inhibites the differentiation of mesenchymal stem cells into osteogenic, adipogenic, chondrogenic, and myogenic lineages", STEM CELLS DEV, 2010
   DI NICOLA, M. ET AL.: "Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli", BLOOD, vol. 99, no. 10, 2002, pages 3838 - 43, XP002982803, DOI: doi:10.1182/blood.V99.10.3838

DOI:   http://dx.doi.org/10.1182/blood.V99.10.3838
   JOHNSON, T.A.; F.R. JIRIK; S. FOUNDER: "Exploring the roles of CD8(+) T lymphocytes in the pathogenesis of autoimmune demyelination", SEMIN IMMUNOPATHOL, vol. 32, no. 2, 2010, pages 197 - 209, XP019843417
   HUSEBY, E.S.; C. OHLEN; J. GOVERMAN: "Cutting edge: myelin basic protein-specific cytotoxic T cell tolerance is maintained in vivo by a single dominant epitope in H-2k mice", J IMMUNOL, vol. 163, no. 3, pages 1115 - 8
   TANG, Q.; J.A. BLUESTONE: "Regulatory T-cellphysiology and application to treat autoimmunity", IMMUNOL REV, vol. 212, 2006, pages 217 - 37, XP002464882, DOI: doi:10.1111/j.0105-2896.2006.00421.x

DOI:   http://dx.doi.org/10.1111/j.0105-2896.2006.00421.x
   BOUMAZA, I. ET AL.: "Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia", J AUTOIMMUN, vol. 32, no. 1, 2009, pages 33 - 4, XP025926169, DOI: doi:10.1016/j.jaut.2008.10.004

DOI:   http://dx.doi.org/10.1016/j.jaut.2008.10.004
   MACCARIO, R. ET AL.: "Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype", HAEMATOLOGICA, vol. 90, no. 4, 2005, pages 516 - 25, XP009111749
   LOCATELLI, F.; R. MACCARIO; F. FRASSONI: "Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders?", HAEMATOLOGICA, vol. 92, no. 7, 2007, pages 872 - 7
   WAN, Y.Y.; R.A. FLAVELL: "Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter", PROC NATL ACAD SCI U S A, vol. 102, no. 14, 2005, pages 5126 - 31
   DUIJVESTEIN ET AL., STEM CELLS, vol. 29, no. 10, 2011, pages 1549 - 1558
   LIANG ET AL., CELL TRANSPLANT, vol. 20, no. 9, 2011, pages 1395 - 1408
   PIZARRO ET AL., TRENDS MOL MED, vol. 9, no. 5, 2003, pages 218 - 222
   COPLAND ET AL., IOVS, vol. 49, no. 12, 2008, pages 5458 - 5465
   WAKITANI ET AL., OSTEOARTHRITIS AND CARTILAGE, vol. 10, 2002, pages 199 - 206
   MOBASHERI ET AL., HISTOL. HISTOPATHOL, vol. 24, no. 3, 2009, pages 347 - 366
   NOTH ET AL., NAT CLIN PRACT RHEUMATO, vol. 4, no. 7, 2008, pages 371 - 380
   GOTHERSTROM ET AL., AM J OBSTET GYNECOL, vol. 190, no. 1, 2004, pages 239 - 45
   RASMUSSON ET AL., EXP. CELL RESEARCH, vol. 312, no. 12, 2006, pages 2169 - 79
   NEWMAN ET AL., INFLAMM ALLERGY DRUG TARGETS, vol. 8, no. 2, 2009, pages 110 - 123
   LE BLANC ET AL., EXP. HEMATOL., vol. 31, 2003, pages 890 - 896
   LIU ET AL., J. OF IMMUNOL., vol. 176, 2006, pages 2864 - 2871
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.